• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OPA1 基因中的基因组缺失导致丹麦常染色体显性视神经萎缩患者发病。

Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy.

机构信息

Center for Applied Human Molecular Genetics, The Kennedy Center, Glostrup, Denmark.

出版信息

BMC Med Genet. 2011 Apr 4;12:49. doi: 10.1186/1471-2350-12-49.

DOI:10.1186/1471-2350-12-49
PMID:21457585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3079616/
Abstract

BACKGROUND

Autosomal dominant optic atrophy (ADOA, Kjer disease, MIM #165500) is the most common form of hereditary optic neuropathy. Mutations in OPA1 located at chromosome 3q28 are the predominant cause for ADOA explaining between 32 and 89% of cases. Although deletions of OPA1 were recently reported in ADOA, the frequency of OPA1 genomic rearrangements in Denmark, where ADOA has a high prevalence, is unknown. The aim of the study was to identify copy number variations in OPA1 in Danish ADOA patients.

METHODS

Forty unrelated ADOA patients, selected from a group of 100 ADOA patients as being negative for OPA1 point mutations, were tested for genomic rearrangements in OPA1 by multiplex ligation probe amplification (MLPA). When only one probe was abnormal results were confirmed by additional manually added probes. Segregation analysis was performed in families with detected mutations when possible.

RESULTS

Ten families had OPA1 deletions, including two with deletions of the entire coding region and eight with intragenic deletions. Segregation analysis was possible in five families, and showed that the deletions segregated with the disease.

CONCLUSION

Deletions in the OPA1 gene were found in 10 patients presenting with phenotypic autosomal dominant optic neuropathy. Genetic testing for deletions in OPA1 should be offered for patients with clinically diagnosed ADOA and no OPA1 mutations detected by DNA sequencing analysis.

摘要

背景

常染色体显性视神经萎缩(ADOA,Kjer 病,MIM#165500)是最常见的遗传性视神经病变形式。位于 3q28 染色体上的 OPA1 突变是 ADOA 的主要原因,占 32%至 89%的病例。尽管最近在 ADOA 中报道了 OPA1 的缺失,但丹麦 ADOA 发病率较高,OPA1 基因组重排的频率尚不清楚。本研究旨在鉴定丹麦 ADOA 患者 OPA1 中的拷贝数变异。

方法

从 100 名 ADOA 患者中选择的 40 名不携带 OPA1 点突变的无关 ADOA 患者,通过多重连接探针扩增(MLPA)检测 OPA1 中的基因组重排。当只有一个探针异常时,通过额外手动添加的探针确认结果。当可能时,对具有检测到突变的家系进行分离分析。

结果

10 个家系存在 OPA1 缺失,包括 2 个整个编码区缺失和 8 个内含子缺失。在 5 个家系中可以进行分离分析,结果显示缺失与疾病共分离。

结论

在表现为常染色体显性视神经病变的 10 名患者中发现了 OPA1 基因缺失。对于临床诊断为 ADOA 且未通过 DNA 测序分析检测到 OPA1 突变的患者,应提供 OPA1 缺失的基因检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b78/3079616/654a305478fd/1471-2350-12-49-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b78/3079616/57c10de0e496/1471-2350-12-49-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b78/3079616/654a305478fd/1471-2350-12-49-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b78/3079616/57c10de0e496/1471-2350-12-49-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b78/3079616/654a305478fd/1471-2350-12-49-2.jpg

相似文献

1
Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy.OPA1 基因中的基因组缺失导致丹麦常染色体显性视神经萎缩患者发病。
BMC Med Genet. 2011 Apr 4;12:49. doi: 10.1186/1471-2350-12-49.
2
Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.OPA1基因重排在常染色体显性遗传性视神经萎缩患者中很常见。
J Med Genet. 2009 Feb;46(2):136-44. doi: 10.1136/jmg.2008.062570.
3
Identification of copy number variation in the gene for autosomal dominant optic atrophy, OPA1, in a Chinese pedigree.一个中国家系中常染色体显性视神经萎缩基因OPA1拷贝数变异的鉴定。
Genet Mol Res. 2015 Sep 21;14(3):10961-72. doi: 10.4238/2015.September.21.8.
4
A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.常染色体显性遗传性视神经萎缩患者OPA1基因突变的全面调查。
Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1715-24.
5
Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicing.导致异常前体mRNA剪接的两个新型OPA1内含子突变的特征分析。
BMC Med Genet. 2017 Feb 28;18(1):22. doi: 10.1186/s12881-017-0383-x.
6
Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.常染色体显性视神经萎缩 OPA1 突变的基因型-表型分析的荟萃分析。
Mitochondrion. 2019 May;46:262-269. doi: 10.1016/j.mito.2018.07.006. Epub 2018 Aug 27.
7
Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.基因组学与蛋白质信息学平台相结合,评估常染色体显性视神经萎缩患者 OPA1 中新型致病性变异 c.1024 A>G(p.K342E)。
Ophthalmic Genet. 2020 Dec;41(6):563-569. doi: 10.1080/13816810.2020.1814344. Epub 2020 Sep 17.
8
Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.八个携带六个新型OPA1致病变体的中国常染色体显性遗传性视神经萎缩家系的临床和遗传特征
Ophthalmic Genet. 2018 Oct;39(5):569-576. doi: 10.1080/13816810.2018.1466337. Epub 2018 Jun 28.
9
Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%.丹麦显性视神经萎缩 - OPA1 中 15 个新突变的报告,使用检测率为 90%的策略。
BMC Med Genet. 2012 Aug 2;13:65. doi: 10.1186/1471-2350-13-65.
10
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.OPA1基因发生突变的常染色体显性遗传性视神经萎缩(ADOA)患者中OPA1亚型表达及凋亡调控的分析
J Neurol Sci. 2015 Apr 15;351(1-2):99-108. doi: 10.1016/j.jns.2015.02.047. Epub 2015 Mar 6.

引用本文的文献

1
Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants.OPA1 基因在一大群可疑显性视神经萎缩患者中的突变谱:48 种新变异体的鉴定和分类。
PLoS One. 2021 Jul 9;16(7):e0253987. doi: 10.1371/journal.pone.0253987. eCollection 2021.
2
First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report.首次发现显性视神经萎缩中 OPA1 基因的亚微观反转 - 病例报告。
BMC Med Genet. 2020 Nov 26;21(1):236. doi: 10.1186/s12881-020-01166-z.
3
Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.

本文引用的文献

1
Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes.BRCA1 和 BRCA2 基因中大片段基因组重排的鉴定和全面特征分析。
Breast Cancer Res Treat. 2010 Aug;122(3):733-43. doi: 10.1007/s10549-009-0613-9. Epub 2009 Nov 6.
2
Axonal loss occurs early in dominant optic atrophy.轴突丢失在显性视神经萎缩的早期发生。
Acta Ophthalmol. 2010 May;88(3):342-6. doi: 10.1111/j.1755-3768.2008.01469.x. Epub 2009 Mar 19.
3
Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report.
八个携带六个新型OPA1致病变体的中国常染色体显性遗传性视神经萎缩家系的临床和遗传特征
Ophthalmic Genet. 2018 Oct;39(5):569-576. doi: 10.1080/13816810.2018.1466337. Epub 2018 Jun 28.
4
Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to mutation status.双侧视神经病变患者的诊断性基因检测及根据突变状态对临床特征的比较。
Mol Vis. 2017 Aug 10;23:548-560. eCollection 2017.
5
Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.显性遗传性视神经萎缩患者OPA1基因杂合性缺失
Jpn J Ophthalmol. 2017 Sep;61(5):395-401. doi: 10.1007/s10384-017-0522-0. Epub 2017 Jul 1.
6
Genetics of Primary Inherited Disorders of the Optic Nerve: Clinical Applications.原发性遗传性视神经疾病的遗传学:临床应用
Cold Spring Harb Perspect Med. 2015 Jul 1;5(7):a017277. doi: 10.1101/cshperspect.a017277.
7
Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics.优势型视神经萎缩、OPA1 和线粒体质量控制:理解线粒体网络动态。
Mol Neurodegener. 2013 Sep 25;8:32. doi: 10.1186/1750-1326-8-32.
8
Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%.丹麦显性视神经萎缩 - OPA1 中 15 个新突变的报告,使用检测率为 90%的策略。
BMC Med Genet. 2012 Aug 2;13:65. doi: 10.1186/1471-2350-13-65.
9
Dominant optic atrophy.优势侧视神经萎缩。
Orphanet J Rare Dis. 2012 Jul 9;7:46. doi: 10.1186/1750-1172-7-46.
10
Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families.OPA1 基因突变导致的视神经萎缩合并表型:两个意大利家系。
J Neurol Sci. 2012 Apr 15;315(1-2):146-9. doi: 10.1016/j.jns.2011.12.002. Epub 2011 Dec 22.
用于检测先天性肾上腺皮质增生症中CYP21A2基因缺失/重复的多重连接依赖探针扩增(MLPA)检测法:首次技术报告
Clin Chim Acta. 2009 Apr;402(1-2):164-70. doi: 10.1016/j.cca.2009.01.008.
4
Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.OPA1基因重排在常染色体显性遗传性视神经萎缩患者中很常见。
J Med Genet. 2009 Feb;46(2):136-44. doi: 10.1136/jmg.2008.062570.
5
Molecular and clinical features associated with CFTR gene rearrangements in Italian population: identification of a new duplication and recurrent deletions.意大利人群中与CFTR基因重排相关的分子和临床特征:一种新的重复和复发性缺失的鉴定。
Clin Genet. 2008 Apr;73(4):346-52. doi: 10.1111/j.1399-0004.2007.00957.x. Epub 2008 Feb 13.
6
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young.青年发病型糖尿病中GCK和HNF1A基因的部分及全基因缺失突变
Diabetologia. 2007 Nov;50(11):2313-7. doi: 10.1007/s00125-007-0798-6. Epub 2007 Sep 8.
7
eOPA1: an online database for OPA1 mutations.eOPA1:一个关于OPA1突变的在线数据库。
Hum Mutat. 2005 May;25(5):423-8. doi: 10.1002/humu.20161.
8
A third locus for dominant optic atrophy on chromosome 22q.22号染色体上显性视神经萎缩的第三个基因座。
J Med Genet. 2005 Jan;42(1):e1. doi: 10.1136/jmg.2004.025502.
9
OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.导致常染色体显性遗传性视神经萎缩和白内障的OPA3基因突变。
J Med Genet. 2004 Sep;41(9):e110. doi: 10.1136/jmg.2003.016576.
10
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.常染色体显性遗传性视神经萎缩中的14种新型OPA1突变,包括散发性视神经萎缩中的两种新发突变。
Hum Mutat. 2003 Jun;21(6):656. doi: 10.1002/humu.9152.